Correlation Engine 2.0
Clear Search sequence regions


  • adult (2)
  • children (2)
  • essential (7)
  • humans (1)
  • medicines (11)
  • therapies (2)
  • Sizes of these terms reflect their relevance to your search.

    A great proportion of the world's cancer burden resides in low- and middle-income countries where cancer care infrastructure is often weak or absent. Although treatment of cancer is multidisciplinary, involving surgery, radiation, systemic therapies, pathology, radiology, and other specialties, selection of medicines that have impact and are affordable has been particularly challenging in resource-constrained settings. In 2014, at the invitation of the WHO, the Union for International Cancer Control convened experts to develop an approach to propose essential cancer medicines to be included in the WHO Model Essential Medicines Lists (EML) for Adults and for Children, as well as a resulting new list of cancer medicines. Experts identified 29 cancer types with potential for maximal treatment impact, on the basis of incidence and benefit of systemic therapies. More than 90 oncology experts from all continents drafted and reviewed disease-based documents outlining epidemiology, diagnostic needs, treatment options, and benefits and toxicities. Briefing documents were created for each disease, along with associated standard treatment regimens, resulting in a list of 52 cancer medicines. A comprehensive application was submitted as a revision to the existing cancer medicines on the WHO Model Lists. In May 2015, the WHO announced the addition of 16 medicines to the Adult EML and nine medicines to the Children's EML. The list of medications proposed, and the ability to link each recommended medicine to specific diseases, should allow public officials to apply resources most effectively in developing and supporting nascent or growing cancer treatment programs. © 2015 by American Society of Clinical Oncology.

    Citation

    Lawrence N Shulman, Claire M Wagner, Ronald Barr, Gilberto Lopes, Giuseppe Longo, Jane Robertson, Gilles Forte, Julie Torode, Nicola Magrini. Proposing Essential Medicines to Treat Cancer: Methodologies, Processes, and Outcomes. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2016 Jan 01;34(1):69-75

    Expand section icon Mesh Tags

    Expand section icon Substances


    PMID: 26578613

    View Full Text